Effect of Genomic Prostate Score on Active Surveillance Selection in African American Population
GPS can predict adverse outcomes in men with prostate cancer and may be used to select patients for active surveillance rather than active treatment.
Prostate Cancer
Prostate Cancer Survival Rates Vary by Gleason Grade Group 5 Pattern
Biopsy Gleason patterns 4+5, 5+4, and 5+5 should be given separate consideration in pretreatment risk stratification, according to investigators.
Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
Black and White Men Had Similar Outcomes After Radical Prostatectomy
Black men were less likely to receive androgen deprivation therapy and had lower use of secondary treatment with radiotherapy.
Nonmetastatic CRPC Treatments Compared for Efficacy and Safety
Investigators compared the efficacy, safety, and costs of abiraterone, darolutamide, enzalutamide, and apalutamide in treating nmCRPC.
PLND Extent During Prostate Surgery Linked With Perioperative Complications
The technical challenges and potential complications of extended PLND warrant careful consideration, according to investigators.
Study Reveals Clinical Heterogeneity of Favorable Intermediate-Risk PCa
Patients’ risk of pathologic upgrading may depend on their intermediate-risk factor (Gleason score 3+4, PSA level of 10-20 ng/mL, and cT2b-c disease).
Open, Robotic-Assisted Prostate Surgery Have Similar Cumulative Costs
Robotic-assisted radical prostatectomy is associated with higher costs than open radical prostatectomy at the index hospitalization for the surgery, but it is associated with less healthcare use during the 1 year after discharge.
British Study Reveals No Race Disparity in Survival in mCRPC Cases
Overall, Black and White men with metastatic castration-resistant prostate cancer had similar median overall survival times, according to a British study.
Ultra-High Single-Dose Radiation Therapy Tested for Prostate Cancer
In a small phase 2 trial involving men with intermediate-risk prostate cancer, a single ultra-high dose of radiation was safe and comparable to curative hypofractionated stereotactic body radiation therapy in tumor control and quality-of-life measures.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...